Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing
Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing
Next Generation Sequencing (NGS) strategy is a powerful tool to identify genes implicated in
 very rare diseases for which the previous genetic explorations remain negative to date. The
 aim of this project is based on groups of patients with original clinical phenotypes
 including neurosensory impairment without genetic cause identified to date. The investigators
 will study these families using whole exome sequencing to potentially identify new genes and
 new underlying biological pathways involved in neurosensory diseases.
Inclusion Criteria:

 -  Original phenotype with neurosensory diseases

 -  Written, informed consent obtained

 Exclusion Criteria:

 -  Refusal to participate at the study

 -  Prior inclusion in a similar study (NGS)